메뉴 건너뛰기




Volumn 13, Issue 4, 2013, Pages 465-468

The hunger hormone ghrelin in cachexia

Author keywords

Anorexia; Cachexia; Cancer; Ghrelin; Uremia

Indexed keywords

GHRELIN; BIOLOGICAL MARKER;

EID: 84879585891     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2013.748031     Document Type: Review
Times cited : (13)

References (23)
  • 2
    • 79955399340 scopus 로고    scopus 로고
    • Definition and classification of cancer cachexia: An international consensus
    • Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011;12:489-95
    • (2011) Lancet Oncol , vol.12 , pp. 489-495
    • Fearon, K.1    Strasser, F.2    Anker, S.D.3
  • 3
    • 79953023673 scopus 로고    scopus 로고
    • The "parallel pathway": A novel nutritional and metabolic approach to cancer patients
    • Muscaritoli M, Molfino A, Gioia G, et al. The "parallel pathway": a novel nutritional and metabolic approach to cancer patients. Intern Emerg Med 2011;6:105-12
    • (2011) Intern Emerg Med , vol.6 , pp. 105-112
    • Muscaritoli, M.1    Molfino, A.2    Gioia, G.3
  • 4
    • 74149087844 scopus 로고    scopus 로고
    • Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: Role as regulators of food intake and body weight
    • Stengel A, Goebel M, Wang L, Tache Y. Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight. Peptides 2010;31:357-69
    • (2010) Peptides , vol.31 , pp. 357-369
    • Stengel, A.1    Goebel, M.2    Wang, L.3    Tache, Y.4
  • 5
    • 49749138909 scopus 로고    scopus 로고
    • NPY and brain monoamines in the pathogenesis of cancer anorexia
    • Laviano A, Inui A, Meguid MM, et al. NPY and brain monoamines in the pathogenesis of cancer anorexia. Nutrition 2008;24:802-5
    • (2008) Nutrition , vol.24 , pp. 802-805
    • Laviano, A.1    Inui, A.2    Meguid, M.M.3
  • 6
    • 0033540056 scopus 로고    scopus 로고
    • Ghrelin is a growth-hormone-releasing acylated peptide from stomach
    • Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-60
    • (1999) Nature , vol.402 , pp. 656-660
    • Kojima, M.1    Hosoda, H.2    Date, Y.3
  • 7
    • 84862150019 scopus 로고    scopus 로고
    • Hypothalamic neuropeptides and the regulation of appetite
    • Parker JA, Bloom SR. Hypothalamic neuropeptides and the regulation of appetite. Neuropharmacology 2012;63:18-30
    • (2012) Neuropharmacology , vol.63 , pp. 18-30
    • Parker, J.A.1    Bloom, S.R.2
  • 8
    • 78449243097 scopus 로고    scopus 로고
    • Neuropeptides in the pathophysiology and treatment of cachexia
    • Krasnow SM, Marks DL. Neuropeptides in the pathophysiology and treatment of cachexia. Curr Opin Support Palliat Care 2010;4:266-71
    • (2010) Curr Opin Support Palliat Care , vol.4 , pp. 266-271
    • Krasnow, S.M.1    Marks, D.L.2
  • 9
    • 81755172017 scopus 로고    scopus 로고
    • Ghrelin, appetite and gastric electrical stimulation
    • Gallas S, Fetissov SO. Ghrelin, appetite and gastric electrical stimulation. Peptides 2011;32:2283-9
    • (2011) Peptides , vol.32 , pp. 2283-2289
    • Gallas, S.1    Fetissov, S.O.2
  • 10
    • 84870894707 scopus 로고    scopus 로고
    • The potential of ghrelin in the treatment of cancer cachexia
    • Argiles JM, Stemmler B. The potential of ghrelin in the treatment of cancer cachexia. Expert Opin Biol Ther 2013;13(1):67-76
    • (2013) Expert Opin Biol Ther , vol.13 , Issue.1 , pp. 67-76
    • Argiles, J.M.1    Stemmler, B.2
  • 11
    • 34250888937 scopus 로고    scopus 로고
    • Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia
    • DeBoer MD, Zhu XX, Levasseur P, et al. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 2007;148:3004-12
    • (2007) Endocrinology , vol.148 , pp. 3004-3012
    • Deboer, M.D.1    Zhu, X.X.2    Levasseur, P.3
  • 12
    • 2942670638 scopus 로고    scopus 로고
    • Ghrelin increases energy intake in cancer patients with impaired appetite: Acute, randomized, placebo-controlled trial
    • Neary NM, Small CJ, Wren AM, et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2004;89:2832-6
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 2832-2836
    • Neary, N.M.1    Small, C.J.2    Wren, A.M.3
  • 13
    • 38549158121 scopus 로고    scopus 로고
    • Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: A randomised, placebo-controlled, double-blind, double-crossover study
    • Strasser F, Lutz TA, Maeder MT, et al. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer 2008;98:300-8
    • (2008) Br J Cancer , vol.98 , pp. 300-308
    • Strasser, F.1    Lutz, T.A.2    Maeder, M.T.3
  • 14
    • 77958185202 scopus 로고    scopus 로고
    • Chronic renal failure, cachexia, and ghrelin
    • doi:10.1155/2010/648045
    • Laviano A, Krznaric Z, Sanchez-Lara K, et al. Chronic renal failure, cachexia, and ghrelin. Int J Pept 2010; doi:10.1155/2010/648045
    • (2010) Int J Pept
    • Laviano, A.1    Krznaric, Z.2    Sanchez-Lara, K.3
  • 15
    • 27744582252 scopus 로고    scopus 로고
    • Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: A randomized, placebo-controlled trial
    • Wynne K, Giannitsopoulou K, Small CJ, et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol 2005;16:2111-18
    • (2005) J Am Soc Nephrol , vol.16 , pp. 2111-2118
    • Wynne, K.1    Giannitsopoulou, K.2    Small, C.J.3
  • 16
    • 67649878152 scopus 로고    scopus 로고
    • Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment
    • Ashby DR, Ford HE, Wynne KJ, et al. Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int 2009;76:199-206
    • (2009) Kidney Int , vol.76 , pp. 199-206
    • Ashby, D.R.1    Ford, H.E.2    Wynne, K.J.3
  • 17
    • 38549149911 scopus 로고    scopus 로고
    • Ghrelin treatment of chronic kidney disease: Improvements in lean body mass and cytokine profile
    • Deboer MD, Zhu X, Levasseur PR, et al. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology 2008;149:827-35
    • (2008) Endocrinology , vol.149 , pp. 827-835
    • Deboer, M.D.1    Zhu, X.2    Levasseur, P.R.3
  • 18
    • 72949107126 scopus 로고    scopus 로고
    • Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease
    • Barazzoni R, Zhu X, Deboer M, et al. Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease. Kidney Int 2010;77:23-8
    • (2010) Kidney Int , vol.77 , pp. 23-28
    • Barazzoni, R.1    Zhu, X.2    Deboer, M.3
  • 19
    • 20844460120 scopus 로고    scopus 로고
    • Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure
    • Nagaya N, Moriya J, Yasumura Y, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004;110:3674-9
    • (2004) Circulation , vol.110 , pp. 3674-3679
    • Nagaya, N.1    Moriya, J.2    Yasumura, Y.3
  • 20
    • 24944473849 scopus 로고    scopus 로고
    • Treatment of cachexia with ghrelin in patients with COPD
    • Nagaya N, Itoh T, Murakami S, et al. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005;128:1187-93
    • (2005) Chest , vol.128 , pp. 1187-1193
    • Nagaya, N.1    Itoh, T.2    Murakami, S.3
  • 21
    • 81255127597 scopus 로고    scopus 로고
    • Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
    • Imazu Y, Yanagi S, Miyoshi K, et al. Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation. Eur J Pharmacol 2011;672:153-8
    • (2011) Eur J Pharmacol , vol.672 , pp. 153-158
    • Imazu, Y.1    Yanagi, S.2    Miyoshi, K.3
  • 22
    • 77949850987 scopus 로고    scopus 로고
    • Effects of ghrelin administration after total gastrectomy: A prospective, randomized, placebo-controlled phase II study
    • Adachi S, Takiguchi S, Okada K, et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology 2010;138:1312-20
    • (2010) Gastroenterology , vol.138 , pp. 1312-1320
    • Adachi, S.1    Takiguchi, S.2    Okada, K.3
  • 23
    • 77953287167 scopus 로고    scopus 로고
    • Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction
    • Yamamoto K, Takiguchi S, Miyata H, et al. Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction. Surgery 2010;148:31-8
    • (2010) Surgery , vol.148 , pp. 31-38
    • Yamamoto, K.1    Takiguchi, S.2    Miyata, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.